Laboratory of America Holdings (LH) Earnings
Price: $230.02
Market Cap: $19.25B
Market Cap: $19.25B
Revenue (TTM): $13.01B
Net Income: $746.00M
Net Income: $746.00M
P/E Ratio: 25.78
EPS (TTM): $8.92
EPS (TTM): $8.92
Earnings Dates
Laboratory of America Holdings (LH) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date: April 24, 2025
- Time of Day: Before Market Open
- Estimated EPS: $3.75
Last Earnings Report
- Date: February 06, 2025
- EPS: $3.45
- EPS Estimate: $3.39
Laboratory of America Holdings's next earnings report is scheduled for April 24, 2025.
In its last earnings report on February 06, 2025, Laboratory of America Holdings reported earnings per share (EPS) of $3.45, compared to an estimated EPS of $3.39. The company reported revenue of $3.33B, compared to an estimated revenue of $3.31B.
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-06 | $3.39 | $3.45 |
| Read Transcript | Q3 | 2024 | 2024-10-24 | $3.47 | $3.50 |
| Read Transcript | Q2 | 2024 | 2024-08-01 | $3.78 | $3.94 |
| Read Transcript | Q1 | 2024 | 2024-04-25 | $3.48 | $3.68 |
| Read Transcript | Q4 | 2023 | 2024-02-15 | $3.29 | $3.30 |
| Read Transcript | Q3 | 2023 | 2023-10-26 | $3.37 | $3.38 |
| Read Transcript | Q2 | 2023 | 2023-07-27 | $3.47 | $3.42 |
| Read Transcript | Q1 | 2023 | 2023-04-25 | $3.99 | $3.82 |
| Read Transcript | Q4 | 2022 | 2023-02-16 | $4.06 | $4.14 |
| Read Transcript | Q3 | 2022 | 2022-10-27 | $4.67 | $4.68 |
| Read Transcript | Q2 | 2022 | 2022-07-28 | N/A | N/A |
| Read Transcript | Q1 | 2022 | 2022-04-28 | N/A | N/A |
| Read Transcript | Q4 | 2021 | 2022-02-10 | N/A | N/A |
| Read Transcript | Q3 | 2021 | 2021-10-28 | N/A | N/A |
| Read Transcript | Q2 | 2021 | 2021-07-29 | N/A | N/A |
| Read Transcript | Q1 | 2021 | 2021-04-29 | N/A | N/A |
| Read Transcript | Q4 | 2020 | 2021-02-11 | N/A | N/A |
| Read Transcript | Q3 | 2020 | 2020-10-27 | N/A | N/A |
| Read Transcript | Q2 | 2020 | 2020-07-28 | N/A | N/A |
| Read Transcript | Q1 | 2020 | 2020-04-29 | N/A | N/A |
| Read Transcript | Q4 | 2019 | 2020-02-13 | N/A | N/A |
| Read Transcript | Q3 | 2019 | 2019-10-24 | N/A | N/A |
| Read Transcript | Q2 | 2019 | 2019-07-25 | N/A | N/A |
| Read Transcript | Q1 | 2019 | 2019-04-30 | N/A | N/A |
| Read Transcript | Q4 | 2018 | 2019-02-07 | N/A | N/A |
| Read Transcript | Q3 | 2018 | 2018-10-24 | N/A | N/A |
| Read Transcript | Q2 | 2018 | 2018-07-25 | N/A | N/A |
| Read Transcript | Q1 | 2018 | 2018-04-25 | N/A | N/A |
| Read Transcript | Q4 | 2017 | 2018-02-06 | N/A | N/A |
| Read Transcript | Q3 | 2017 | 2017-10-27 | N/A | N/A |
| Read Transcript | Q2 | 2017 | 2017-07-26 | N/A | N/A |
| Read Transcript | Q1 | 2017 | 2017-04-26 | N/A | N/A |
| Read Transcript | Q4 | 2016 | 2017-02-16 | N/A | N/A |
| Read Transcript | Q3 | 2016 | 2016-10-26 | N/A | N/A |
| Read Transcript | Q2 | 2016 | 2016-07-27 | N/A | N/A |
| Read Transcript | Q1 | 2016 | 2016-04-25 | N/A | N/A |
Earnings History
| Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
|---|---|---|---|---|
| February 06, 2025 | $3.45 | $3.39 | $3.33B | $3.31B |
| October 24, 2024 | $3.50 | $3.47 | $3.28B | $3.26B |
| August 01, 2024 | $3.94 | $3.78 | $3.22B | $3.19B |
| April 25, 2024 | $3.68 | $3.48 | $3.18B | $3.12B |
| February 15, 2024 | $3.30 | $3.29 | $3.03B | $3.02B |
| October 26, 2023 | $3.38 | $3.37 | $3.06B | $2.99B |
| July 27, 2023 | $3.42 | $3.47 | $3.03B | $3.15B |
| April 25, 2023 | $3.82 | $3.99 | $3.78B | $3.69B |
| February 16, 2023 | $4.14 | $4.06 | $3.67B | $3.74B |
| October 27, 2022 | $4.68 | $4.67 | $3.61B | $3.79B |
| July 28, 2022 | $4.95 | $4.70 | $3.70B | $3.75B |
| April 28, 2022 | $6.11 | $5.98 | $3.90B | $4.01B |
| February 10, 2022 | $6.77 | $5.80 | $4.06B | $3.92B |
| October 28, 2021 | $6.82 | $4.92 | $4.06B | $3.60B |
| July 29, 2021 | $6.13 | $5.53 | $3.84B | $3.84B |
| April 29, 2021 | $8.79 | $7.43 | $4.16B | $3.93B |
| February 11, 2021 | $10.56 | $8.11 | $4.49B | $3.13B |
| October 27, 2020 | $8.41 | $5.31 | $3.90B | $2.46B |
| July 28, 2020 | $2.57 | $1.00 | $2.77B | $1.08B |
Annual Earnings
Annual Revenue
$13.01B
Fiscal Year 2024Annual Net Income
$746.00M
Fiscal Year 2024Annual EPS
$8.92
Fiscal Year 2024Quarterly Earnings
Revenue
$3.33B
Quarter Ending December 31, 2024Net Income
$143.40M
Quarter Ending December 31, 2024EPS
$1.72
Quarter Ending December 31, 2024Earnings Metrics
Earnings Yield
3.89%
Year Ending December 31, 2024P/E Ratio
25.70
Year Ending December 31, 2024Revenue Per Share
$155.61
Year Ending December 31, 2024Earnings Yield (TTM)
3.88%
Trailing Twelve MonthsP/E Ratio (TTM)
25.78
Trailing Twelve MonthsRevenue Per Share (TTM)
$155.61
Trailing Twelve MonthsFrequently Asked Questions
Laboratory of America Holdings's next earnings date is scheduled for April 24, 2025. The earnings call is expected to take place before market open.
In its last earnings report on February 06, 2025, Laboratory of America Holdings reported earnings per share (EPS) of $3.45, compared to an estimated EPS of $3.39. The company reported revenue of $3.33B, compared to an estimated revenue of $3.31B.
Laboratory of America Holdings's current Price-to-Earnings (P/E) ratio is 25.70. The trailing twelve months (TTM) P/E ratio is 25.78. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2024, Laboratory of America Holdings reported total revenue of $13.01B and net income of $746.00M. This represents a net profit margin of 0.0573453559.
Laboratory of America Holdings's earnings yield is 3.89%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
Laboratory of America Holdings's return on equity (ROE) is 9.26%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
Laboratory of America Holdings's gross profit margin is 26.92%. This indicates that for every dollar of revenue, the company retains $0.27 as gross profit after accounting for the cost of goods sold.
Related Metrics
Explore detailed financial metrics and analysis for LH.